UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients

Journal of the American Society of Nephrology, 2001-07, Vol.12 (7), p.1508-1515

2001

Volltextzugriff (PDF)

Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients

American journal of kidney diseases, 2002-07, Vol.40 (1), p.68-75

2002

Volltextzugriff (PDF)

Diagnostic potential of cardiac natriuretic peptides in dialysis patients

Kidney international, 2001-04, Vol.59 (4), p.1559-1566

2001

Volltextzugriff (PDF)

Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease

Journal of the American Society of Nephrology, 2002, Vol.13 (1), p.134-141

2002

Volltextzugriff (PDF)

Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease

Circulation (New York, N.Y.), 2002-03, Vol.105 (11), p.1354-1359

2002

Volltextzugriff (PDF)

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study

The Lancet (British edition), 2001-12, Vol.358 (9299), p.2113-2117

2001

Volltextzugriff (PDF)

Norepinephrine and Concentric Hypertrophy in Patients With End-Stage Renal Disease

Hypertension (Dallas, Tex. 1979), 2002-07, Vol.40 (1), p.41-46

2002

Volltextzugriff (PDF)

Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors

Kidney international, 2003-05, Vol.63 (S84), p.S98-S102

2003

Volltextzugriff (PDF)

Long‐term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients

Nephrology, dialysis, transplantation, 2001-07, Vol.16 (7), p.1459-1464

2001

Volltextzugriff (PDF)

Adiponectin in essential hypertension

Journal of nephrology, 2002-09, Vol.15 (5), p.507-511

2002

Volltextzugriff (PDF)

Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients

Kidney international, 2002-11, Vol.62 (5), p.1884-1890

2002

Volltextzugriff (PDF)

Prospective study of neuropeptide Y as an adverse cardiovascular risk factor in end-stage renal disease

Journal of the American Society of Nephrology, 2003-10, Vol.14 (10), p.2611-2617

2003

Volltextzugriff (PDF)

Chlamydia pneumoniae, overall and cardiovascular mortality in end-stage renal disease (ESRD)

Kidney international, 2003-08, Vol.64 (2), p.579-584

2003

Volltextzugriff (PDF)

Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease

Journal of hypertension, 2003-07, Vol.21 (7), p.1355-1362

2003

Volltextzugriff (PDF)

Low parathyroid hormone and pentosidine in hemodialysis patients

American journal of kidney diseases, 2002-10, Vol.40 (4), p.810-815

2002

Volltextzugriff (PDF)

Plasma adrenomedullin during acute changes in intravascular volume in hemodialysis patients

Kidney international, 1998-11, Vol.54 (5), p.1697-1703

1998

Volltextzugriff (PDF)

Gender-dependent differences in plasma leptin in essential hypertension

American journal of hypertension, 2000-08, Vol.13 (8), p.914-920

2000

Volltextzugriff (PDF)

Urinary adrenomedullin is related to ET-1 and salt intake in patients with mild essential hypertension

American journal of hypertension, 2001-03, Vol.14 (3), p.224-230

2001

Volltextzugriff (PDF)

Hepatocyte Growth Factor and Left Ventricular Geometry in End-Stage Renal Disease

Hypertension (Dallas, Tex. 1979), 2003-01, Vol.41 (1), p.88-92

2003

Volltextzugriff (PDF)

Neuropeptide Y left ventricular mass and function in patients with end stage renal disease. Commentary

Journal of hypertension, 2003, Vol.21 (7), p.1355-1264

2003

Volltextzugriff (PDF)

The influence of volume depletion and central hypovolemia on the plasma concentration of parathyroid hormone in dialysis patients

Journal of the American Society of Nephrology, 1997-10, Vol.8 (10), p.1574-1578

1997

Volltextzugriff (PDF)

The influence of salt intake on plasma calcitonin gene-related peptide in subjects with mild essential hypertension

Journal of hypertension, 1994-11, Vol.12 (11), p.1249-1254

1994

Volltextzugriff (PDF)

Influence of cardiovascular damage and residual renal function on plasma endothelin in chronic renal failure

Nephron (2015), 1993, Vol.63 (3), p.291-295

1993

Volltextzugriff (PDF)

Severe rhabdomyolysis induced by a retard formulation of bezafibrate in a CAPD patient

Nephron (2015), 1996, Vol.73 (4), p.736-736

1996

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)
Japanisch
(4)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients

Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients

Diagnostic potential of cardiac natriuretic peptides in dialysis patients

Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease

Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study

Norepinephrine and Concentric Hypertrophy in Patients With End-Stage Renal Disease

Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors

Long‐term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients

Circulating Natriuretic Peptide Concentrations in Patients With End-Stage Renal Disease: Role of Brain Natriuretic Peptide as a Biomarker for Ventricular Remodeling

Adiponectin in essential hypertension

Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients

Prospective study of neuropeptide Y as an adverse cardiovascular risk factor in end-stage renal disease

Chlamydia pneumoniae, overall and cardiovascular mortality in end-stage renal disease (ESRD)

Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease

Low parathyroid hormone and pentosidine in hemodialysis patients

Plasma adrenomedullin during acute changes in intravascular volume in hemodialysis patients

Gender-dependent differences in plasma leptin in essential hypertension

Urinary adrenomedullin is related to ET-1 and salt intake in patients with mild essential hypertension

Hepatocyte Growth Factor and Left Ventricular Geometry in End-Stage Renal Disease

Neuropeptide Y left ventricular mass and function in patients with end stage renal disease. Commentary

The influence of volume depletion and central hypovolemia on the plasma concentration of parathyroid hormone in dialysis patients

The influence of salt intake on plasma calcitonin gene-related peptide in subjects with mild essential hypertension

Influence of cardiovascular damage and residual renal function on plasma endothelin in chronic renal failure

Severe rhabdomyolysis induced by a retard formulation of bezafibrate in a CAPD patient

Suchergebnisse filtern